I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic ...

Getting your Trinity Audio player ready... Colorado’s new prescription drug review board decided in a first-in-the-nation vote that a medication costing more than $200,000 a year doesn’t qualify as ...

COLORADO (KCNC) — Some Coloradans are sounding an alarm after learning a state board is considering capping the price of a life-saving drug. They’re worried the move could cause the manufacturer to ...

For people with cystic fibrosis, like Sabrina Walker, Trikafta has been a life-changer. Before she started taking the drug, she would wind up in the hospital for weeks at a time until antibiotics ...

Noah’s parents celebrate a major breakthrough as Trikafta becomes available, offering their son with cystic fibrosis a ...

Colorado’s new prescription drug review board decided in a first-in-the-nation vote that a medication costing more than $200,000 a year doesn’t qualify as “unaffordable,” based on the drug’s benefits ...

CHANNAHON, Ill. (WLS) -- Brandon Wolfe enjoys spending quality time with his family. Playing with his young sons wasn't always easy, but he has a lot more energy to play after testing a new drug to ...

Credit: Vertex. According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment. An additional 94 non-F508del CFTR mutations and a boxed warning ...

And while this was all true for Christchurch youngster Noah Harrington-Ashton, his recent celebrations also marked the ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 7.9% in the past three months. One major reason for the weakness ...

Add Yahoo as a preferred source to see more of our stories on Google. The author’s daughter, Rose Keller, during a recent inpatient stay at Boston Children’s Hospital. (Photo courtesy of Donald Kreis; ...